Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT04051606
Brief Title: Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

First Submitted : August 7, 2019
First Submitted that Met QC Criteria : August 7, 2019
First Posted : August 9, 2019

Last Update Submitted that Met QC Criteria : August 23, 2019
Last Update Posted : August 28, 2019